OptiBiotix Health (OPTI) Competitors GBX 17.75 -1.50 (-7.79%) (As of 12/20/2024 12:19 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines OPTI vs. KOD, ORPH, AMPH, ANW, AURA, MRK, PHE, REVB, CYAN, and OKYOShould you be buying OptiBiotix Health stock or one of its competitors? The main competitors of OptiBiotix Health include Kodal Minerals (KOD), Open Orphan (ORPH), Aggregated Micro Power (AMPH), Aberdeen New Thai Investment Trust (ANW), Aura Energy (AURA), Marks Electrical Group (MRK), PowerHouse Energy Group (PHE), Revolution Beauty Group (REVB), CyanConnode (CYAN), and OKYO Pharma (OKYO). These companies are all part of the "pharmaceutical products" industry. OptiBiotix Health vs. Kodal Minerals Open Orphan Aggregated Micro Power Aberdeen New Thai Investment Trust Aura Energy Marks Electrical Group PowerHouse Energy Group Revolution Beauty Group CyanConnode OKYO Pharma OptiBiotix Health (LON:OPTI) and Kodal Minerals (LON:KOD) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their community ranking, risk, profitability, dividends, media sentiment, institutional ownership, valuation, earnings and analyst recommendations. Is OPTI or KOD more profitable? Kodal Minerals' return on equity of 75.19% beat OptiBiotix Health's return on equity.Company Net Margins Return on Equity Return on Assets OptiBiotix HealthN/A -36.34% -13.93% Kodal Minerals N/A 75.19%-5.71% Which has more volatility & risk, OPTI or KOD? OptiBiotix Health has a beta of 1.71, suggesting that its stock price is 71% more volatile than the S&P 500. Comparatively, Kodal Minerals has a beta of 0.51, suggesting that its stock price is 49% less volatile than the S&P 500. Does the media prefer OPTI or KOD? In the previous week, Kodal Minerals had 2 more articles in the media than OptiBiotix Health. MarketBeat recorded 2 mentions for Kodal Minerals and 0 mentions for OptiBiotix Health. Kodal Minerals' average media sentiment score of 0.45 beat OptiBiotix Health's score of 0.00 indicating that Kodal Minerals is being referred to more favorably in the news media. Company Overall Sentiment OptiBiotix Health Neutral Kodal Minerals Neutral Which has stronger earnings & valuation, OPTI or KOD? Kodal Minerals has lower revenue, but higher earnings than OptiBiotix Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOptiBiotix Health£1.26M13.80-£2.98M-£0.03-591.67Kodal MineralsN/AN/A£27.19MN/AN/A Does the MarketBeat Community prefer OPTI or KOD? OptiBiotix Health received 32 more outperform votes than Kodal Minerals when rated by MarketBeat users. However, 62.78% of users gave Kodal Minerals an outperform vote while only 59.18% of users gave OptiBiotix Health an outperform vote. CompanyUnderperformOutperformOptiBiotix HealthOutperform Votes14559.18% Underperform Votes10040.82% Kodal MineralsOutperform Votes11362.78% Underperform Votes6737.22% Do insiders & institutionals have more ownership in OPTI or KOD? 4.9% of OptiBiotix Health shares are owned by institutional investors. Comparatively, 0.0% of Kodal Minerals shares are owned by institutional investors. 12.0% of OptiBiotix Health shares are owned by company insiders. Comparatively, 30.1% of Kodal Minerals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Do analysts prefer OPTI or KOD? Kodal Minerals has a consensus price target of GBX 1.45, indicating a potential upside of 313.11%. Given Kodal Minerals' stronger consensus rating and higher possible upside, analysts clearly believe Kodal Minerals is more favorable than OptiBiotix Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OptiBiotix Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Kodal Minerals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryKodal Minerals beats OptiBiotix Health on 10 of the 14 factors compared between the two stocks. Ad Investors AlleyCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69% dividend from Tesla… Which could put up to $7,013 in your pocket every month…Click here to discover the new #1 way to invest in Tesla Get OptiBiotix Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OPTI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OPTI vs. The Competition Export to ExcelMetricOptiBiotix HealthBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£17.38M£164.65M£5.14B£1.88BDividend YieldN/A3.64%5.09%5.54%P/E Ratio-591.67115.5190.051,810.29Price / Sales13.8018,239.951,117.14382,807.21Price / Cash8.6812.7543.0428.42Price / Book2.228.504.782.91Net Income-£2.98M-£20.67M£120.31M£156.83M7 Day Performance-16.27%-1.04%-1.92%-1.92%1 Month Performance44.90%136.65%11.51%17.93%1 Year Performance-26.89%137.57%30.61%29.50% OptiBiotix Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OPTIOptiBiotix HealthN/AGBX 17.75-7.8%N/A-26.9%£17.38M£1.26M-591.671High Trading VolumeKODKodal MineralsN/AGBX 0.35+2.9%GBX 1.45+310.2%-8.8%£71.58MN/A0.0090News CoverageGap DownORPHOpen OrphanN/AGBX 10+5.3%N/A+0.0%£67.09M£34.71M-25.30179AMPHAggregated Micro PowerN/AN/AN/AN/A£64.54M£49.33M70.771,620Gap UpANWAberdeen New Thai Investment TrustN/AGBX 398-1.0%N/A+0.0%£63.63M£2.08M120.615AURAAura EnergyN/AGBX 7-3.4%N/A-50.2%£55.31M£92,496.00-700.0050High Trading VolumeMRKMarks Electrical Group1.3088 of 5 starsGBX 52.50flatGBX 100+90.5%-42.2%£54.96M£114.26M1,613.00200News CoveragePHEPowerHouse Energy GroupN/AGBX 1.17+8.3%N/A+222.1%£49.14M£680,842.00-138.004Gap UpREVBRevolution Beauty GroupN/AGBX 15.02-5.4%N/A-55.6%£47.96M£191.29M500.8010Gap DownCYANCyanConnodeN/AGBX 9.20flatN/A+12.7%£31.98M£18.73M-920.00100Gap DownOKYOOKYO PharmaN/AGBX 1.40-24.3%N/AN/A£23.24MN/A-140.007News CoverageGap Down Related Companies and Tools Related Companies Kodal Minerals Alternatives Open Orphan Alternatives Aggregated Micro Power Alternatives Aberdeen New Thai Investment Trust Alternatives Aura Energy Alternatives Marks Electrical Group Alternatives PowerHouse Energy Group Alternatives Revolution Beauty Group Alternatives CyanConnode Alternatives OKYO Pharma Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:OPTI) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptiBiotix Health Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share OptiBiotix Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.